Belano, Roweno L.
HRN: 26-88-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
CEFTAZIDIME 1GM (VIAL)
03/24/2025
03/31/2025
IV
1g
Every 8 Hours
DM Foot, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes